Publications by authors named "Michelle Byrtek"

Claim this Profile
E
Evaluation of the effect of prospective biomarker testing on progression-free survival in diffuse large B-cell lymphoma.
Edith Szafer-Glusman, Juan Liu, Arijit Sinha, Franklin V Peale, Jill Ray, Michelle Byrtek

Leuk Lymphoma· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice.
Ida Wong-Sefidan, Michelle Byrtek, Xiaolei Zhou, Jonathan W Friedberg, Christopher R Flowers

Leuk Lymphoma· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma.
Thomas Powles, Mark R Lackner, Stéphane Oudard, Bernard Escudier, Christy Ralph, Michelle Byrtek

J Clin Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, Ryan Ziemiecki, Xiaolei Zhou

Br J Haematol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS).
Nina D Wagner-Johnston, Brian K Link, Michelle Byrtek, Keith L Dawson, John Hainsworth

Blood· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.
Carla Casulo, Michelle Byrtek, Keith L Dawson, Xiaolei Zhou, Charles M Farber

J Clin Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.
Chadi Nabhan, Michelle Byrtek, Ashish Rai, Keith Dawson, Xiaolei Zhou

Br J Haematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States.
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, Ryan Ziemiecki, Michael Taylor

Leuk Lymphoma· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, Xiaolei Zhou, Michael D Taylor

Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study.
Peter Martin, Michelle Byrtek, Keith Dawson, Ryan Ziemiecki, Jonathan W Friedberg

Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study.
Chadi Nabhan, Michelle Byrtek, Michael D Taylor, Jonathan W Friedberg, James R Cerhan

Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study.
Jonathan W Friedberg, Michelle Byrtek, Brian K Link, Christopher Flowers, Michael Taylor

J Clin Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis